Kazia Therapeutics (KZIA) Total Current Liabilities (2017 - 2025)
Kazia Therapeutics (KZIA) has disclosed Total Current Liabilities for 4 consecutive years, with $17.0 million as the latest value for Q2 2024.
- For the quarter ending Q2 2024, Total Current Liabilities changed N/A year-over-year to $17.0 million, compared with a TTM value of $17.0 million through Jun 2024, changed N/A, and an annual FY2024 reading of $16.9 million, changed N/A over the prior year.
- Total Current Liabilities was $17.0 million for Q2 2024 at Kazia Therapeutics, up from $3.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $17.0 million in Q2 2024 and bottomed at $3.4 million in Q2 2022.